Gemmer Asset Management’s Eli Lilly LLY Stock Holding History

Gemmer Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.41M	Buy	1,179 +8	+0.7%	+$8.17K	0.1%	68
2026 Q1	$1.08M	Sell	1,171 -55	-4%	-$55.8K	0.09%	78
2025 Q4	$1.32M	Buy	1,226 +227	+23%	+$217K	0.1%	75
2025 Q3	$763K	Sell	999 -25	-2%	-$18.6K	0.06%	90
2025 Q2	$798K	Sell	1,024 -67	-6%	-$52.1K	0.07%	85
2025 Q1	$901K	Hold	1,091	–	–	0.09%	75
2024 Q4	$843K	Buy	1,091 +51	+5%	+$42.2K	0.08%	79
2024 Q3	$921K	Sell	1,040 -7	-0.7%	-$6.29K	0.09%	74
2024 Q2	$948K	Buy	1,047 +23	+2%	+$18.4K	0.1%	64
2024 Q1	$797K	Hold	1,024	–	–	0.09%	66
2023 Q4	$597K	Sell	1,024 -316	-24%	-$184K	0.07%	68
2023 Q3	$720K	Buy	1,340 +587	+78%	+$302K	0.1%	59
2023 Q2	$353K	Hold	753	–	–	0.05%	92
2023 Q1	$259K	Hold	753	–	–	0.04%	107
2022 Q4	$275K	Hold	753	–	–	0.04%	98
2022 Q3	$243K	Buy	+753	New	+$239K	0.04%	106
2022 Q2	–	Sell	-553	Closed	-$158K	–	674
2022 Q1	$158K	Sell	553 -52	-9%	-$13.4K	0.02%	133
2021 Q4	$167K	Hold	605	–	–	0.02%	134
2021 Q3	$140K	Hold	605	–	–	0.02%	133
2021 Q2	$139K	Sell	605 -78	-11%	-$15.7K	0.02%	144
2021 Q1	$128K	Buy	683 +90	+15%	+$17.6K	0.02%	140
2020 Q4	$100K	Hold	593	–	–	0.02%	146
2020 Q3	$88K	Hold	593	–	–	0.02%	137
2020 Q2	$97K	Hold	593	–	–	0.02%	128
2020 Q1	$82K	Hold	593	–	–	0.02%	124
2019 Q4	$78K	Hold	593	–	–	0.02%	147
2019 Q3	$66K	Sell	593 -275	-32%	-$30.6K	0.02%	166
2019 Q2	$96K	Hold	868	–	–	0.03%	124
2019 Q1	$113K	Sell	868 -249	-22%	-$30.3K	0.03%	115
2018 Q4	$129K	Buy	1,117 +167	+18%	+$18.7K	0.04%	98
2018 Q3	$102K	Hold	950	–	–	0.03%	112
2018 Q2	$81K	Hold	950	–	–	0.03%	134
2018 Q1	$74K	Hold	950	–	–	0.03%	142
2017 Q4	$80K	Buy	950 +300	+46%	+$25.5K	0.03%	141
2017 Q3	$56K	Hold	650	–	–	0.02%	163
2017 Q2	$53K	Hold	650	–	–	0.02%	169
2017 Q1	$55K	Hold	650	–	–	0.02%	169
2016 Q4	$48K	Hold	650	–	–	0.02%	171
2016 Q3	$52K	Sell	650 -130	-17%	-$10.4K	0.03%	166
2016 Q2	$61K	Hold	780	–	–	0.03%	136
2016 Q1	$56K	Buy	780 +130	+20%	+$9.84K	0.03%	150
2015 Q4	$55K	Sell	650 -495	-43%	-$41.1K	0.03%	148
2015 Q3	$96K	Hold	1,145	–	–	0.06%	106
2015 Q2	$96K	Sell	1,145 -100	-8%	-$7.62K	0.06%	111
2015 Q1	$90K	Sell	1,245 -50	-4%	-$3.56K	0.05%	115
2014 Q4	$89K	Hold	1,295	–	–	0.06%	111
2014 Q3	$84K	Buy	1,295 +100	+8%	+$6.33K	0.06%	119
2014 Q2	$74K	Hold	1,195	–	–	0.05%	130
2014 Q1	$70K	Buy	+1,195	New	+$66.7K	0.05%	134

Other funds holding LLY

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Gemmer Asset Management's LLY Position: Q2 2026 in Review

Gemmer Asset Management increased its Eli Lilly (LLY) stake by 0.68% in Q2 2026, buying an estimated $8.17K and bringing the position to 1,179 shares worth $1.41M. The position accounts for 0.1% of the portfolio, ranked #68.

Gemmer Asset Management first reported a position in LLY in Q1 2014 and has held it in 49 quarters since. 987 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Gemmer Asset Management held 1,179 shares of Eli Lilly worth $1.41M as of Q2 2026.
Gemmer Asset Management bought 8 Eli Lilly shares in Q2 2026, an estimated $8.17K.
Eli Lilly made up 0.1% of Gemmer Asset Management's portfolio in Q2 2026, its #68 holding.
Gemmer Asset Management first reported a position in Eli Lilly in Q1 2014 and has held it in 49 quarters since.
987 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Gemmer Asset Management's 13F filing for Q2 2026, filed 15 Jul 2026.